AmCad BioMed Corporation
4188
Rank in Stocks
#25312
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Share Price
$0.42068553
Last synced: 2026-11-10
Market Cap
$26.64M
Change (1 day)
-1.43%
Change (1 year)
-16.72%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AmCad BioMed Corporation (4188)
Category
Technology
Operating Margin for AmCad BioMed Corporation (4188)
Operating Margin as of November 2026 TTM: -303.03%
According to AmCad BioMed Corporation's latest financial reports, its current operating margin (TTM) is -303.03%. At the end of 2025 the company had an operating margin of -288.97%.
Operating Margin history for AmCad BioMed Corporation from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -303.03% | 4.87% |
| 2025 | -288.97% | 137.31% |
| 2024 | -121.77% | 47.19% |
| 2023 | -82.73% | -6.06% |
| 2022 | -88.07% | 181.46% |
| 2021 | -31.29% | -53.29% |
| 2020 | -66.99% | 0.07% |
| 2019 | -66.94% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 27.42% | -100.09% |
DE
|
|
| 13.90% | -100.05% |
CA
|
|
| 21.39% | -100.07% |
US
|
|
| 12.47% | -100.04% |
US
|
|
| 77.44% | -100.26% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about AmCad BioMed Corporation's operating margin
What is AmCad BioMed Corporation's operating margin?
AmCad BioMed Corporation's operating margin is -303.03%, as of Nov 2026.
What was AmCad BioMed Corporation's operating margin in 2025?
In 2025, AmCad BioMed Corporation's operating margin was -288.97%, compared with -121.77% in 2024.
How has AmCad BioMed Corporation's operating margin changed since 2020?
From 2020 to 2025, AmCad BioMed Corporation's operating margin was highest in 2021 (-31.29%) and lowest in 2025 (-288.97%).
How does AmCad BioMed Corporation's operating margin compare with similar companies?
AmCad BioMed Corporation's operating margin (-303.03%) is lower than that of all 5 similar companies listed above. The highest among them is AppLovin Corporation, with 77.44%.